Journey Medical Corporation
NASDAQ:DERM
Overview | Financials
Company Name | Journey Medical Corporation |
Symbol | DERM |
Currency | USD |
Price | 3.73 |
Market Cap | 77,919,458 |
Dividend Yield | 0% |
52-week-range | 2.85 - 6.89 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Claude Maraoui |
Website | https://journeymedicalcorp.com |
An error occurred while fetching data.
About Journey Medical Corporation
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD